News

Department of Pathology Alumni Newsletter, Issue 9
As the summer winds down, I hope you and your families, colleagues, and friends continue to stay safe during this pandemic. At UCSF, we continue to navigate the COVID-19 crisis at many levels, including the operational and financial challenges...

Department of Pathology Alumni Newsletter, Issue 8
This newsletter is one we had originally planned to send about this time before the COVID-19 pandemic. I am not going into detail about our response again, but I do want to give you the brief followup that our pathology team is continuing the plan...
Department of Pathology Alumni Newsletter, Issue 7
This newsletter arrives to you under much different circumstances while we deal with the COVID-19 pandemic.
Department of Pathology Alumni Newsletter, Issue 6
The General Hospital is undergoing one of the most dynamic and exciting times since its inception.
Department of Pathology Alumni Newsletter, Issue 5
It is hard to believe that I have already started my second year serving as the Director of Cytopathology at UCSF.
Department of Pathology Alumni Newsletter, Issue 4
I recognized early in my training that there is something special about the UCSF Department of Pathology.
Department of Pathology Alumni Newsletter, Issue 3
Alumni and Friends, What is the best attribute of our Department? My response has always been: the dedicated staff, residents, fellows and faculty who actively engage and drive change.
Department of Pathology Alumni Newsletter, Issue 2
Dear Alumni and Friends,

It is a wonderful honor and pleasure for me to be recently appointed as the Chair of Pathology.
Department of Pathology Alumni Newsletter, Issue 1
The UCSF Pathology Department is launching a newsletter to tell you about developments in the Department and encourage you to get involved in our activities.
Dr. Thea Tlsty, PhD, is a winner of CRUK's “Grand Challenge”
UC San Francisco Professor Thea Tlsty, PhD, is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK (CRUK), an ambitious international funding initiative that aims to answer some of the biggest open questions in cancer...